Exane Derivatives’s Finisar Corp FNSR Stock Holding History

Exane Derivatives’s Portfolio FNSR Stock Details FNSR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,300	Closed	-$121K	–	717
2019 Q2	$121K	Hold	5,300	–	–	0.02%	311
2019 Q1	$123K	Sell	5,300 -20,233	-79%	-$462K	0.02%	272
2018 Q4	$551K	Sell	25,533 -24,010	-48%	-$478K	0.1%	170
2018 Q3	$943K	Sell	49,543 -10,368	-17%	-$193K	0.18%	114
2018 Q2	$1.08M	Buy	59,911 +7,191	+14%	+$119K	0.18%	123
2018 Q1	$804K	Buy	52,720 +24,684	+88%	+$466K	0.16%	133
2017 Q4	$570K	Buy	28,036 +4,568	+19%	+$95K	0.1%	153
2017 Q3	$520K	Buy	+23,468	New	+$575K	0.1%	134

Other funds holding FNSR

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VAM

Verity Asset Management Durham, North Carolina $264M AUM 28.52% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Exane Derivatives's FNSR Position: Q3 2019 in Review

Exane Derivatives sold out of Finisar Corp (FNSR) in Q3 2019, closing a stake of 5,300 shares — an estimated $121K sold.

Exane Derivatives first reported a position in FNSR in Q3 2017 and held it in 8 quarters. The position peaked at $1.08M in Q2 2018. 21 funds tracked by Wall St. Rank hold FNSR as of Q3 2019.

Exane Derivatives reported no remaining Finisar Corp position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 5,300 Finisar Corp shares in Q3 2019, an estimated $121K.
Exane Derivatives first reported a position in Finisar Corp in Q3 2017 and held it in 8 quarters.
Exane Derivatives's Finisar Corp position peaked at $1.08M in Q2 2018.
21 funds tracked by Wall St. Rank held Finisar Corp as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.